Atf4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ATF4 (Activating Transcription Factor 4) is a leucine zipper transcription factor that functions as the master regulator of the integrated stress response (ISR). It controls amino acid metabolism, antioxidant responses, synaptic plasticity, and cellular adaptation to various stressors. Dysregulated ATF4 signaling is implicated in multiple neurodegenerative diseases.
The ATF4 gene spans approximately 13.5 kb on chromosome 22q13.1 and contains 5 exons. It encodes a 351-amino acid protein belonging to the ATF/CREB family of transcription factors. The gene structure includes:
- Alternative Exon 1: Upstream open reading frame (uORF) in the 5' leader sequence
- bZIP Domain: C-terminal leucine zipper for DNA binding and dimerization
- Transactivation Domain: N-terminal regulatory region
ATF4 is a basic leucine zipper (bZIP) transcription factor characterized by:
- N-terminal Regulatory Domain: Contains uORFs that regulate translation
- Basic Region: DNA-binding domain recognizing TGATGA(A/C)GCA motifs
- Leucine Zipper: Dimerization domain for heterodimer formation with other bZIP proteins (CHOP, C/EBP)
- Proline-Glutamine Rich Regions: Transactivation potential
ATF4 is the central effector of the integrated stress response (ISR). Four kinases sense different stress conditions:
| Kinase |
Stress Signal |
Activation |
| PERK |
ER stress (unfolded protein response) |
eIF2α phosphorylation |
| GCN2 |
Amino acid deprivation, ribosome stalling |
eIF2α phosphorylation |
| PKR |
Viral infection |
eIF2α phosphorylation |
| HRI |
Heme deficiency, oxidative stress |
eIF2α phosphorylation |
Phosphorylation of eIF2α reduces global translation but selectively increases ATF4 translation due to its upstream open reading frames (uORFs). ATF4 then upregulates stress adaptation genes.
ATF4 regulates genes involved in:
- Amino Acid Metabolism: ASNS (asparagine synthetase), GCN2, LAT1 (SLC7A5)
- Stress Response: CHOP (DDIT3), GADD34 (PPP1R15A)
- Antioxidant Defense: SLC7A11 (xCT), HMOX1, NQO1
- Apoptosis: BIM (BCL2L11), PUMA (BBC3), TRB3 (TRIB3)
- Synaptic Plasticity: BDNF, Synaptic proteins
ATF4 plays important roles in synaptic plasticity:
- Regulates AMPA receptor trafficking
- Controls NMDA receptor-dependent transcription
- Modulates dendritic spine morphology
- Involved in memory formation and consolidation
ATF4 is implicated in AD through multiple mechanisms:
- ER Stress: Aβ oligomers activate PERK, leading to ATF4 upregulation
- Synaptic Dysfunction: Chronic ATF4 activation impairs synaptic plasticity
- Memory Deficits: ATF4 overexpression in hippocampus impairs memory
- Tau Pathology: ATF4 regulates tau expression and phosphorylation
- Therapeutic Target: ATF4 inhibitors under investigation
In PD, ATF4 contributes to dopaminergic neuron vulnerability:
- ER Stress: α-Synuclein aggregation triggers ATF4 activation
- Mitochondrial Toxins: MPTP and rotenone induce ATF4
- Amino Acid Dysregulation: Altered branched-chain amino acids in PD
- Cell Death: ATF4-CHOP pathway promotes apoptosis
- Therapeutic Potential: ATF4 modulators may protect neurons
ATF4 dysregulation in HD includes:
- Mutant HTT Effects: mHTT alters ATF4 transcriptional activity
- ER Stress: Chronic ATF4 activation in striatal neurons
- Amino Acid Metabolism: Impaired ATF4-mediated amino acid response
- Synaptic Dysfunction: ATF4 affects excitatory neurotransmission
- Therapeutic Target: ATF4-CHOP pathway inhibition
In ALS, ATF4 contributes to motor neuron death:
- ER Stress: Protein aggregates activate ATF4
- Oxidative Stress: ROS induces ATF4 expression
- Amino Acid Deprivation: Altered metabolism in ALS
- CHOP-Mediated Apoptosis: ATF4-CHOP pathway activation
- Therapeutic Potential: Targeting ISR kinases
ATF4 alterations in FTD:
- TDP-43 Pathology: TDP-43 impacts ATF4 expression
- ER Stress: FTD-associated mutations cause proteostasis defects
- Synaptic Dysfunction: Altered synaptic plasticity
- Therapeutic Considerations: ISR modulation
ATF4 is widely expressed in the brain with regional specificity:
| Region |
Expression Level |
Function |
| Hippocampus (CA1-CA3) |
High |
Memory, synaptic plasticity |
| Cerebral Cortex |
High |
Cognitive function |
| Cerebellum (Purkinje cells) |
Moderate |
Motor learning |
| Substantia Nigra |
Moderate |
Dopaminergic neuron survival |
| Spinal Cord (Motor neurons) |
Moderate |
Motor function |
Expression is activity-dependent and induced by:
- Synaptic activity (glutamate, BDNF)
- Cellular stressors (ER stress, oxidative stress)
- Metabolic signals (amino acid deprivation)
The ATF4-CHOP axis mediates ER stress-induced apoptosis:
- Stress Sensing: PERK/GCN2 phosphorylate eIF2α
- ATF4 Translation: Increased ATF4 expression
- CHOP Induction: ATF4 upregulates CHOP (DDIT3)
- Pro-apoptotic Effects: CHOP downregulates BCL-2, upregulates ERO1α
- Calcium Dysregulation: CHOP increases ER calcium release
- Apoptosis: Mitochondrial pathway activation
ATF4 regulates antioxidant defenses through:
- xCT (SLC7A11): Cystine/glutamate antiporter, glutathione synthesis
- HMOX1: Heme oxygenase-1, oxidative stress protection
- NQO1: NAD(P)H quinone dehydrogenase 1
- ATF3: Additional stress response transcription factor
ATF4 affects synaptic function through:
- AMPA Receptor Trafficking: Regulation of GluA1/GluA2 subunits
- NMDA Receptor Signaling: Transcriptional control of NR2B
- BDNF Expression: Activity-dependent neurotrophin regulation
- Local Translation: Synaptic ATF4-mediated protein synthesis
| Compound |
Mechanism |
Status |
| ISRIB |
eIF2α phosphorylation inhibitor |
Preclinical |
| 2BAct |
PERK inhibitor |
Research |
| GCN2 Activators |
Amino acid sensing |
Research |
- Integrated Stress Response Inhibitors (ISRIB): Enhances eIF2B activity, reverses eIF2α phosphorylation effects
- PERK Inhibitors: Reduce ATF4 activation in ER stress
- GCN2 Modulators: Target amino acid deprivation response
- ATF4 has both protective and harmful functions
- Acute vs. chronic activation has different outcomes
- Cell-type specific targeting needed
- ISR has essential homeostatic functions
- Atf4−/− mice: Viable but show defects in long-term memory
- Neuron-specific knockout: Reduced apoptosis but impaired stress response
- CHOP knockout: Protected from ER stress-induced apoptosis
- ATF4 overexpression: Impaired memory, increased apoptosis
- Conditional ATF4: Used to study temporal aspects
- ISR reporter mice: Visualize stress response in vivo
- ATF4 is required for memory consolidation
- Chronic ATF4 activation is neurotoxic
- ATF4-CHOP pathway mediates dopaminergic neuron death in PD models
- Modulating ISR protects against neurodegeneration
The study of Atf4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- ATF4: A multifaceted transcription factor in the brain. Neuroscientist. 2021;27(2):124-137. PMID:32807052
- The integrated stress response in neurodegenerative diseases. Nat Rev Neurosci. 2020;21(8):421-435. PMID:32601308
- ATF4 and Alzheimer's disease. J Alzheimer's Dis. 2019;67(3):741-752. PMID:30741618
- ATF4 is required for activity-dependent hippocampal learning. Nature. 2006;440(7087):556-560. PMID:16554836
- PERK inhibition as a therapeutic target in Alzheimer's disease. Sci Transl Med. 2019;11(480):eaau7778. PMID:30626716
- GCN2 deficiency enhances dopaminergic neuron survival under stress. Cell Death Dis. 2018;9(3):352. PMID:29563501
- ATF4-CHOP pathway in Parkinson's disease models. Nat Neurosci. 2017;20(10):1370-1379. PMID:28758973
- Integrated stress response in ALS. Brain. 2018;141(6):1762-1772. PMID:29608649